<DOC>
	<DOC>NCT02344264</DOC>
	<brief_summary>The patients will be included the 1. or 2. day after surgery. All THA patients will be screened. Those reporting VAS &gt; 40 during active 30 degrees hip flexion will be asked to participate. Included patients will receive 2xNCFL (singleshot) first placebo (8 ml saline) and then ropivacaine (8 ml ropivacaine 7,5mg/ml) or the other way around (randomized). There will be 45 minutes between the two blockades. The blockades will be ultrasound guided.</brief_summary>
	<brief_title>Effect of Nervus Cutaneous Femoris Lateralis-Blockade on Moderate Pain Responders After Total Hip Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>THA within 48 hours and VAS&gt;40 during active 30 degrees hip flexion despite conventional pain medication. informed consent ASA 13 BMI 1840 Unable to communicate in danish Allergic reactions toward drugs used Abuse of alcohol/drugs Unable to cooperate Pregnant women</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>US guided nerve block</keyword>
	<keyword>Total hip Arthroplasty</keyword>
	<keyword>NCFL</keyword>
	<keyword>nervus cutaneous femoralis lateralis</keyword>
</DOC>